RDGT vs PBH vs SPB vs CHD vs PG

For growth investors, Church & Dwight Co.

, Inc. (CHD) is the stronger pick with 1. 6% revenue growth year-over-year, versus -22. 4% for Ridgetech Inc. (RDGT). Prestige Consumer Healthcare Inc. (PBH) offers the better valuation at 12. 2x trailing P/E (11. 6x forward), making it the more compelling value choice. Analysts rate Prestige Consumer Healthcare Inc. (PBH) a "Buy" — based on 17 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Prestige Consumer Healthcare Inc.

(PBH) is the cheapest at 12. 2x versus Church & Dwight Co. , Inc. at 30. 9x. On forward P/E, Prestige Consumer Healthcare Inc. is actually cheaper at 11. 6x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Spectrum Brands Holdings, Inc. wins at 1. 20x versus The Procter & Gamble Company's 3. 80x — a reasonable growth-adjusted valuation.

Over the past 5 years, The Procter & Gamble Company (PG) delivered a total return of +20.

4%, compared to -100. 0% for Ridgetech Inc. (RDGT). Over 10 years, the gap is even starker: PG returned +119. 7% versus RDGT's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), The Procter & Gamble Company (PG) is the lower-risk stock at 0.

13β versus Ridgetech Inc. 's 1. 27β — meaning RDGT is approximately 848% more volatile than PG relative to the S&P 500. On balance sheet safety, Spectrum Brands Holdings, Inc. (SPB) carries a lower debt/equity ratio of 34% versus 68% for The Procter & Gamble Company — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Church & Dwight Co.

, Inc. (CHD) is pulling ahead at 1. 6% versus -22. 4% for Ridgetech Inc. (RDGT). On earnings-per-share growth, the picture is similar: Ridgetech Inc. grew EPS 162. 8% year-over-year, compared to -5. 6% for Spectrum Brands Holdings, Inc.. Over a 3-year CAGR, CHD leads at 4. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

The Procter & Gamble Company (PG) is the more profitable company, earning 19.

0% net margin versus 3. 6% for Spectrum Brands Holdings, Inc. — meaning it keeps 19. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: PBH leads at 29. 6% versus -0. 9% for RDGT. At the gross margin level — before operating expenses — PBH leads at 55. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Spectrum Brands Holdings, Inc. (SPB) is the more undervalued stock at a PEG of 1. 20x versus The Procter & Gamble Company's 3. 80x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Prestige Consumer Healthcare Inc. (PBH) trades at 11. 6x forward P/E versus 24. 9x for Church & Dwight Co. , Inc. — 13. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for PBH: 25. 6% to $66. 00.

In this comparison, PG (2.

7% yield), SPB (2. 3% yield), CHD (1. 3% yield) pay a dividend. RDGT, PBH do not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, The Procter & Gamble Company (PG) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

13), 2. 7% yield, +119. 7% 10Y return). Both have compounded well over 10 years (PG: +119. 7%, RDGT: -100. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (RDGT (Healthcare) and PBH (Healthcare) and SPB (Consumer Defensive) and CHD (Consumer Defensive) and PG (Consumer Defensive)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: RDGT is a small-cap quality compounder stock; PBH is a small-cap deep-value stock; SPB is a small-cap quality compounder stock; CHD is a mid-cap quality compounder stock; PG is a large-cap quality compounder stock. SPB, CHD, PG pay a dividend while RDGT, PBH do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.